BMS1P18: A Protein with Potential as A Drug Target Or Biomarker

Target Name: BMS1P18

NCBI ID: G414763

BMS1P18

Other Name(s): LINC00516 | BMS1 pseudogene 18 | Long intergenic non-protein coding RNA 516 | C14orf17 | Ribosome biogenesis protein BMS1 homolog pseudogene

BMS1P18: A Protein with Potential as A Drug Target Or Biomarker

BMS1P18 (LINC00516) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of core histone-associated proteins (CHAPs), which are known for their role in the regulation of gene expression and DNA replication.

One of the unique features of BMS1P18 is its ability to interact with the protein p16INK4a. p16INK4a is a key regulator of the cell cycle, and it has been implicated in a wide range of cellular processes, including cell growth, apoptosis, and inflammation. BMS1P18 has been shown to physically interact with p16INK4a, and this interaction has been used as a target for the development of new pharmaceuticals.

In addition to its interaction with p16INK4a, BMS1P18 has also been shown to play a role in the regulation of cellular processes that are important for brain development and function. For example, BMS1P18 has been shown to be involved in the regulation of neuron survival and differentiation, and it has been shown to play a role in the development of neurodegenerative diseases.

Despite the potential importance of BMS1P18 as a drug target, much more research is needed to fully understand its function and properties. One of the challenges in studying BMS1P18 is its ubiquity, as it is expressed in many different tissues and cells of the body. In order to study its effects, researchers have used a variety of techniques, including RNA interference, overexpression, and live cell assays, to try to understand its role in different cellular processes.

In addition to its potential as a drug target, BMS1P18 also has potential as a biomarker for a wide range of diseases. For example, BMS1P18 has been shown to be expressed in various types of cancer, and it has been used as a biomarker for cancer diagnosis and treatment. In addition, BMS1P18 has also been shown to be involved in the regulation of cellular processes that are important for many other diseases, including neurodegenerative diseases, autoimmune diseases, and diseases that are caused by environmental factors, such as pollution or radiation.

Overall, BMS1P18 is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. Further research is needed to fully understand its function and properties, and to determine its potential as a therapeutic agent.

Protein Name: BMS1 Pseudogene 18

The "BMS1P18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BMS1P18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets